Emergent BioSolutions Inc. (EBS)

NYSE: EBS · IEX Real-Time Price · USD

1.950

-0.230 (-10.55%)

At close: Apr 25, 2024, 4:00 PM

1.990

+0.040 (2.05%)

After-hours: Apr 25, 2024, 7:52 PM EDT

Emergent BioSolutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Revenue	1,049	1,118	1,774	1,577	1,106	782.4	560.9	488.8	489.33	404.47	Upgrade
Revenue Growth (YoY)	-6.10%	-36.99%	12.45%	42.61%	41.36%	39.49%	14.75%	-0.11%	20.98%	29.33%	Upgrade
Cost of Revenue	705.4	693.1	748.1	537	433.5	322.3	187.7	126.3	107.49	101.96	Upgrade
Gross Profit	343.9	424.4	1,026	1,040	672.5	460.1	373.2	362.5	381.85	302.5	Upgrade
Selling, General & Admin	368.4	339.5	348.7	304.1	273.5	202.5	142.9	143.1	121.15	108.59	Upgrade
Research & Development	111.4	188.3	235.2	237.9	226.2	142.8	97.4	106.9	119.19	104.72	Upgrade
Other Operating Expenses	590.5	66.6	100.2	59.8	58.7	25	8.6	7	0	0	Upgrade
Operating Expenses	1,070	594.4	684.1	601.8	558.4	370.3	248.9	257	240.33	213.32	Upgrade
Operating Income	-726.4	-170	341.4	438.5	114.1	89.8	124.3	105.5	141.51	89.19	Upgrade
Interest Expense / Income	87.9	37.3	34.5	31.3	38.4	9.9	6.6	7.6	6.52	8.24	Upgrade
Other Expense / Income	-83.1	11.7	3.7	-4.7	-1.7	-1.6	-0.9	9.4	27.82	14.28	Upgrade
Pretax Income	-731.2	-219	303.2	411.9	77.4	81.5	118.6	88.5	107.17	66.67	Upgrade
Income Tax	29.3	-7.4	83.7	106.1	22.9	18.8	36	36.7	44.3	29.93	Upgrade
Net Income	-760.5	-211.6	219.5	305.8	54.5	62.7	82.6	51.8	62.87	36.74	Upgrade
Net Income Growth	-	-	-28.22%	461.10%	-13.08%	-24.09%	59.46%	-17.61%	71.12%	18.01%	Upgrade
Shares Outstanding (Basic)	51	50	54	53	52	50	42	40	39	37	Upgrade
Shares Outstanding (Diluted)	51	50	54	54	52	51	50	49	47	46	Upgrade
Shares Change	2.20%	-7.39%	0.56%	2.67%	1.95%	2.19%	2.03%	4.33%	3.17%	24.64%	Upgrade
EPS (Basic)	-14.85	-4.22	4.10	5.80	1.06	1.25	1.98	1.29	1.63	0.98	Upgrade
EPS (Diluted)	-14.85	-4.22	4.06	5.68	1.04	1.22	1.71	1.13	1.41	0.88	Upgrade
EPS Growth	-	-	-28.52%	446.15%	-14.75%	-28.65%	51.33%	-19.86%	60.23%	3.53%	Upgrade
Free Cash Flow	-257.9	-149.9	96.1	395	101.1	-30.3	153.3	-21.6	-2.3	81.65	Upgrade
Free Cash Flow Per Share	-5.04	-2.99	1.80	7.50	1.96	-0.60	3.67	-0.54	-0.06	2.19	Upgrade
Gross Margin	32.77%	37.98%	57.82%	65.95%	60.80%	58.81%	66.54%	74.16%	78.03%	74.79%	Upgrade
Operating Margin	-69.23%	-15.21%	19.25%	27.80%	10.32%	11.48%	22.16%	21.58%	28.92%	22.05%	Upgrade
Profit Margin	-72.48%	-18.94%	12.38%	19.39%	4.93%	8.01%	14.73%	10.60%	12.85%	9.08%	Upgrade
Free Cash Flow Margin	-24.58%	-13.41%	5.42%	25.04%	9.14%	-3.87%	27.33%	-4.42%	-0.47%	20.19%	Upgrade
Effective Tax Rate	-	-	27.61%	25.76%	29.59%	23.07%	30.35%	41.47%	41.34%	44.89%	Upgrade
EBITDA	-518.2	-38.4	461.5	557.7	226.5	153.6	167.8	134.3	149.03	107.36	Upgrade
EBITDA Margin	-49.39%	-3.44%	26.02%	35.36%	20.48%	19.63%	29.92%	27.48%	30.46%	26.54%	Upgrade
Depreciation & Amortization	125.1	143.3	123.8	114.5	110.7	62.2	42.6	38.2	35.34	32.45	Upgrade
EBIT	-643.3	-181.7	337.7	443.2	115.8	91.4	125.2	96.1	113.69	74.91	Upgrade
EBIT Margin	-61.31%	-16.26%	19.04%	28.10%	10.47%	11.68%	22.32%	19.66%	23.23%	18.52%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).